ISRCTN27242710已完成不适用
A phase II trial of docetaxel in the treatment of elderly patients (aged 70 or over) with non-small cell lung cancer
Maidstone and Tunbridge Wells NHS Trust (UK)0 个研究点目标入组 55 人开始时间: 2008年1月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged greater than or equal to 70 on the day of first treatment
- •2. Histologically or cytologically confirmed NSCLC
- •3. Any stage not suitable for surgery or radical radiotherapy
- •4. Radiologically evaluable disease (by Response Evaluation Criteria In Solid Tumours [RECIST] criteria) of at least one measurable lesion on chest X-ray (CXR) or computed tomography (CT)
- •5. Performance status World Health Organization (WHO) of 0, 1 or 2
- •6. Life expectancy greater than 12 weeks
- •7. Adequate haematological and biochemical function
排除标准
- •1. Prior chemotherapy (previous surgery and palliative radiotherapy are allowed)
- •2. Uncontrolled non-cancer systemic disease
- •3. Significant clinical or laboratory abnormalities
- •4. Concomitant or previous malignancy likely to interfere with treatment outcome
- •5. WHO performance status of worse than 2
- •6. Inadequate renal function
- •7. Inadequate bone marrow function
研究者
相似试验
已完成
2 期
Phase II study of docetaxel monotherapy plus primary prophylaxis with pegfilgrastim for pre-treated locally advanced or metastatic non-small cell lung cancer.JPRN-UMIN000016383Dept. Respiratory Medicine, Osaka Police Hopital31
招募中
1 期
Investigation of therapeutic efficacy of docetaxel, cisplatin and S1 (DCS) chemotherapy for advanced or recurrent gastric cancerAdvanced/Recurrent Gastric cancerJPRN-UMIN000019972Teikyo University Chiba Medical Center40
进行中（未招募）
1 期
Phase II Trial of Docetaxel in Patients With Metastatic or Inoperable Medullary Thyroid CancerMetastatic or inoperable medullary thyroid cancerEUCTR2006-005301-63-ATniversity Hospital Vienna
招募中
不适用
Clinical Phase I / II trial of weekly docetaxel therapy in conjunction with radiation in case of FP therapy refractory cases in esophageal cancerEsophageal cancerJPRN-UMIN000030593The Jikei University school of medicine40
已完成
1 期
Phase I/II trial of weekly docetaxel and concomitant radiotherapy for unresectable esophageal squamous cell carcinoma after induction chemothrapynresectable esophageal squamous cell carcinoma after induction chemotherapyJPRN-UMIN000004856Gastroenterologic surgery, Kanazawa university44